The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3
- PMID: 11137993
- DOI: 10.1038/83713
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3
Abstract
IPEX is a fatal disorder characterized by immune dysregulation, polyendocrinopathy, enteropathy and X-linked inheritance (MIM 304930). We present genetic evidence that different mutations of the human gene FOXP3, the ortholog of the gene mutated in scurfy mice (Foxp3), causes IPEX syndrome. Recent linkage analysis studies mapped the gene mutated in IPEX to an interval of 17-20-cM at Xp11. 23-Xq13.3.
Similar articles
-
A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA-->AAUGAA) leads to the IPEX syndrome.Immunogenetics. 2001 Aug;53(6):435-9. doi: 10.1007/s002510100358. Immunogenetics. 2001. PMID: 11685453
-
Mechanistic associations of a mild phenotype of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome.Clin Gastroenterol Hepatol. 2006 May;4(5):653-9. doi: 10.1016/j.cgh.2005.12.014. Clin Gastroenterol Hepatol. 2006. PMID: 16630773
-
Immune reconstitution and recovery of FOXP3 (forkhead box P3)-expressing T cells after transplantation for IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome.Pediatrics. 2008 Apr;121(4):e998-1002. doi: 10.1542/peds.2007-1863. Epub 2008 Mar 3. Pediatrics. 2008. PMID: 18316354
-
IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena.Curr Opin Pediatr. 2001 Dec;13(6):533-8. doi: 10.1097/00008480-200112000-00007. Curr Opin Pediatr. 2001. PMID: 11753102 Review.
-
Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis.Curr Opin Rheumatol. 2003 Jul;15(4):430-5. doi: 10.1097/00002281-200307000-00010. Curr Opin Rheumatol. 2003. PMID: 12819471 Review.
Cited by
-
Targeting Tregs in Malignant Brain Cancer: Overcoming IDO.Front Immunol. 2013 May 15;4:116. doi: 10.3389/fimmu.2013.00116. eCollection 2013. Front Immunol. 2013. PMID: 23720663 Free PMC article.
-
Depleting tumor-specific Tregs at a single site eradicates disseminated tumors.J Clin Invest. 2013 Jun;123(6):2447-63. doi: 10.1172/JCI64859. J Clin Invest. 2013. PMID: 23728179 Free PMC article.
-
Clinical and immunological characteristics of five patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome in China-expanding the atypical phenotypes.Front Immunol. 2022 Aug 24;13:972746. doi: 10.3389/fimmu.2022.972746. eCollection 2022. Front Immunol. 2022. PMID: 36091011 Free PMC article.
-
Targeting regulatory T cells in the treatment of type 1 diabetes mellitus.Curr Mol Med. 2012 Dec;12(10):1261-72. doi: 10.2174/156652412803833634. Curr Mol Med. 2012. PMID: 22709273 Free PMC article. Review.
-
Age-Related Changes in Thymic Central Tolerance.Front Immunol. 2021 Apr 22;12:676236. doi: 10.3389/fimmu.2021.676236. eCollection 2021. Front Immunol. 2021. PMID: 33968086 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
